• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-2 缺乏可损害载脂蛋白 E 缺陷小鼠的主动脉粥样硬化钙化。

Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice.

机构信息

Department of Anatomy and Neuroscience, Hamamatsu University School of Medicine, 1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan.

出版信息

Atherosclerosis. 2013 Mar;227(1):43-50. doi: 10.1016/j.atherosclerosis.2012.12.008. Epub 2012 Dec 19.

DOI:10.1016/j.atherosclerosis.2012.12.008
PMID:23312504
Abstract

OBJECTIVE

Matrix metalloproteinases (MMPs) have been implicated in the process of vascular calcification. However, the exact roles of individual MMPs in vascular calcification are poorly understood. To study the putative role of MMP-2 in atherogenic calcification in vivo and in vitro, we investigate whether or not MMP-2 deficiency affects aortic atherosclerotic calcification in apolipoprotein E-deficient (Apoe(-/-)) mice and cultured smooth muscle cell (SMC) calcification.

METHODS AND RESULTS

The area of calcified lesions in aortic intima was significantly larger in MMP-2(+/+) Apoe(-/-) mice at 45 and 60 weeks of age than in MMP-2(-/-) Apoe(-/-) mice. In these aortic calcified atherosclerotic lesions, the expression of type II collagen, osteoprotegerin, bone morphogenetic protein (BMP)-2 and osteocalcin which are chondrocyte maker and bone-related proteins, was observed. MMP-2 deficiency reduced BMP-2 and osteocalcin expression in aortae in Apoe(-/-) mice at 30 weeks and 45-60-weeks-old, respectively. The expressions of MMP-2 and that of α-SMC actin were observed in chondrocyte-like cells of calcified lesions. Beta-glycerophosphate administration induced calcium deposition in MMP-2(+/+) aorta-derived cultured SMCs, and this calcium deposition was significantly suppressed in MMP-2(-/-) aorta-derived cultured SMCs.

CONCLUSIONS

These results suggest that MMP-2 may contribute to the mechanisms of calcification associated with atherosclerosis.

摘要

目的

基质金属蛋白酶(MMPs)被认为参与了血管钙化的过程。然而,个体 MMP 在血管钙化中的确切作用仍知之甚少。为了研究 MMP-2 在动脉粥样硬化钙化中的潜在作用,我们研究了 MMP-2 缺陷是否会影响载脂蛋白 E 缺陷(Apoe(-/-))小鼠的主动脉粥样硬化钙化和培养的平滑肌细胞(SMC)钙化。

方法和结果

在 45 周和 60 周龄时,MMP-2(+/+)Apoe(-/-)小鼠的主动脉内膜钙化病变面积明显大于 MMP-2(-/-)Apoe(-/-)小鼠。在这些主动脉钙化性动脉粥样硬化病变中,观察到了Ⅱ型胶原、骨保护素、骨形态发生蛋白-2(BMP-2)和骨钙素的表达,这些是软骨细胞标志物和骨相关蛋白。MMP-2 缺陷分别降低了 30 周和 45-60 周龄 Apoe(-/-)小鼠主动脉中 BMP-2 和骨钙素的表达。在钙化病变的软骨样细胞中观察到 MMP-2 和α-SMC 肌动蛋白的表达。β-甘油磷酸钠诱导 MMP-2(+/+)主动脉源性培养的 SMC 中钙沉积,而 MMP-2(-/-)主动脉源性培养的 SMC 中钙沉积显著受到抑制。

结论

这些结果表明,MMP-2 可能参与了与动脉粥样硬化相关的钙化机制。

相似文献

1
Matrix metalloproteinase-2 deficiency impairs aortic atherosclerotic calcification in ApoE-deficient mice.基质金属蛋白酶-2 缺乏可损害载脂蛋白 E 缺陷小鼠的主动脉粥样硬化钙化。
Atherosclerosis. 2013 Mar;227(1):43-50. doi: 10.1016/j.atherosclerosis.2012.12.008. Epub 2012 Dec 19.
2
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.晚期糖基化终产物 Nε-羧甲基赖氨酸促进糖尿病动脉粥样硬化钙化的进展。
Atherosclerosis. 2012 Apr;221(2):387-96. doi: 10.1016/j.atherosclerosis.2012.01.019. Epub 2012 Jan 13.
3
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.TRAIL 缺陷通过调节 RANKL 加速动脉粥样硬化中的血管钙化。
PLoS One. 2013 Sep 5;8(9):e74211. doi: 10.1371/journal.pone.0074211. eCollection 2013.
4
Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo.旁分泌成骨信号通过骨形态发生蛋白-2 加速体内动脉粥样硬化内膜钙化。
Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1908-15. doi: 10.1161/ATVBAHA.110.206185. Epub 2010 Jul 22.
5
Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice.基质金属蛋白酶-2缺乏对载脂蛋白E缺乏小鼠动脉粥样硬化病变形成的影响。
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1120-5. doi: 10.1161/01.ATV.0000218496.60097.e0. Epub 2006 Mar 23.
6
Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification.骨髓或血管壁来源的护骨素足以减少动脉粥样硬化病变的大小和血管钙化。
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2491-500. doi: 10.1161/ATVBAHA.113.301755. Epub 2013 Aug 29.
7
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.骨保护素失活加速老年载脂蛋白E基因敲除小鼠晚期动脉粥样硬化病变进展和钙化。
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2117-24. doi: 10.1161/01.ATV.0000236428.91125.e6. Epub 2006 Jul 13.
8
The P2Y nucleotide receptor is an inhibitor of vascular calcification.P2Y核苷酸受体是血管钙化的一种抑制剂。
Atherosclerosis. 2017 Feb;257:38-46. doi: 10.1016/j.atherosclerosis.2016.12.014. Epub 2016 Dec 15.
9
Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice.间质干细胞减轻载脂蛋白 E 缺陷型小鼠血管紧张素 II 诱导的主动脉瘤生长。
J Vasc Surg. 2011 Dec;54(6):1743-52. doi: 10.1016/j.jvs.2011.06.109. Epub 2011 Sep 9.
10
The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.1a型血管紧张素II受体缺乏对高胆固醇血症诱导的动脉粥样硬化的长期影响。
Hypertens Res. 2008 Aug;31(8):1631-42. doi: 10.1291/hypres.31.1631.

引用本文的文献

1
Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification.平滑肌细胞特异性基质金属蛋白酶 3 缺失可减少成骨转化和中动脉钙化。
Cardiovasc Res. 2024 May 7;120(6):658-670. doi: 10.1093/cvr/cvae035.
2
Supplement of exogenous inorganic pyrophosphate inhibits atheromatous calcification in Apolipoprotein E knockout mice.补充外源性无机焦磷酸可抑制载脂蛋白E基因敲除小鼠的动脉粥样硬化钙化。
Heliyon. 2023 Aug 16;9(8):e19214. doi: 10.1016/j.heliyon.2023.e19214. eCollection 2023 Aug.
3
Illuminating the potential causality of serum level of matrix metalloproteinases and the occurrence of cardiovascular and cerebrovascular diseases: a Mendelian randomization study.
揭示基质金属蛋白酶血清水平与心脑血管疾病发生的潜在因果关系:一项孟德尔随机化研究。
J Hum Genet. 2023 Sep;68(9):615-624. doi: 10.1038/s10038-023-01154-0. Epub 2023 Apr 28.
4
Signaling pathways in vascular function and hypertension: molecular mechanisms and therapeutic interventions.血管功能和高血压中的信号通路:分子机制和治疗干预。
Signal Transduct Target Ther. 2023 Apr 20;8(1):168. doi: 10.1038/s41392-023-01430-7.
5
Association of Matrix Metalloproteinases with Coronary Artery Calcification in Patients with CHD.冠心病患者中基质金属蛋白酶与冠状动脉钙化的关联
J Pers Med. 2021 Jun 3;11(6):506. doi: 10.3390/jpm11060506.
6
Ulinastatin attenuates monocyte-endothelial adhesion via inhibiting ROS transfer between the neighboring vascular endothelial cells mediated by Cx43.乌司他丁通过抑制由Cx43介导的相邻血管内皮细胞间的活性氧转移来减轻单核细胞与内皮细胞的黏附。
Am J Transl Res. 2020 Aug 15;12(8):4326-4336. eCollection 2020.
7
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.基质金属蛋白酶作为动脉粥样硬化斑块不稳定的生物标志物。
Int J Mol Sci. 2020 May 31;21(11):3946. doi: 10.3390/ijms21113946.
8
Promotes Inflammatory Programs in Human and Murine Macrophages and Alters Atherosclerosis Lesion Composition in the Apolipoprotein E Deficient Mouse.促进人源和鼠源巨噬细胞中的炎症程序,并改变载脂蛋白 E 缺陷型小鼠中的动脉粥样硬化病变组成。
Front Immunol. 2020 Mar 30;11:397. doi: 10.3389/fimmu.2020.00397. eCollection 2020.
9
Macrophage-derived MMP-9 enhances the progression of atherosclerotic lesions and vascular calcification in transgenic rabbits.巨噬细胞衍生的 MMP-9 增强了转基因兔动脉粥样硬化病变和血管钙化的进展。
J Cell Mol Med. 2020 Apr;24(7):4261-4274. doi: 10.1111/jcmm.15087. Epub 2020 Mar 3.
10
Role of Thioredoxin in Age-Related Hypertension.硫氧还蛋白在年龄相关性高血压中的作用。
Curr Hypertens Rep. 2018 Feb 14;20(1):6. doi: 10.1007/s11906-018-0815-9.